← Back to product files

RECORD 10 / REVIEW / 6 MIN READ

Theramid Copper Peptide review: confirm the label behind the percentage

A 3% manufacturer claim, differing ingredient records, and a current shopping-page limitation worth keeping visible.

THE DETAIL TO KEEP

The official indexed record is informative, but incomplete direct access and differing ingredient records prevent us from confirming the formula in a current shipment.

Sections in this fieldnote

Theramid Copper Peptide deserves a review that spends as much time on the source record as on the number in its name. The official indexed product page describes a 3% copper-peptide treatment, but the ingredient records available during this research were not consistent enough to identify what a new shipment will contain with confidence.

On September 26, 2026, an indexed official record was readable through web retrieval, while direct access and TinyFish returned mostly a generic store shell. We report that limitation rather than inventing a verified checkout offer. CoreAge Rx holds this publication’s sponsored first position; that placement does not resolve Theramid’s formulation questions or prove a performance advantage.

Separate the product claim from independent confirmation

The indexed manufacturer record identifies a 30 mL product, names Copper Tripeptide-1, and advertises 3% copper peptide alongside a separate peptide complex. Those statements establish the brand’s description. We did not test ingredient purity, concentration, stability, or delivery into skin, and the product name cannot stand in for that testing.

A percentage is useful only after its meaning is established. It should not become an effectiveness multiplier against a 1% serum, a 2% cream, or a formula with no disclosed amount. The percentage fieldnote explains why identity, the basis of the number, and the finished preparation need to stay together.

A higher advertised concentration also does not automatically answer a sensitive-skin question. The rest of the formula and the user’s history remain relevant. A product review should not convert a large front-label number into a reason for someone to escalate an existing routine.

The ingredient records need reconciliation

The official indexed page we inspected listed a broad formula that included Copper Tripeptide-1 and Retinyl Palmitate. A separate indexed regional record displayed a different list. The retrieval difference does not establish when a reformulation occurred, whether the products are regional variants, or which carton a retailer will ship today.

That is a practical purchasing gap. Ask the brand or seller for the full ingredient declaration on the actual available package and identify the destination market. Keep any response with the product record, especially when avoiding a particular ingredient or coordinating cosmetic use with a prescription.

Our label-change guide offers a method for comparing records without assuming that a changed list proves contamination or counterfeiting. In this case, the responsible conclusion is that confirmation is needed. It is not an accusation against the manufacturer or a claim that one search result represents every bottle.

Read the warning as product-specific information

The indexed official record warns against combining the product with other acids or retinoids and against use on irritated or damaged skin. Its ingredient declaration also includes vitamin-related ingredients. That combination of information calls for a question about the exact finished formula, rather than an improvised chemistry rule from this review.

Do not delete a prescribed treatment from your care plan simply to make room for a cosmetic serum. Bring the actual product list and manufacturer instructions to the prescriber if compatibility is uncertain. The layering fieldnote explains how different brands can give different instructions without creating one universal rule for every copper product.

We do not reproduce the page’s application frequency as a personal schedule. A reader who has not yet established which formulation is being supplied should first resolve that identity question. Directions from a different market or older formula may not answer it.

Cosmetic language does not establish a medical use

The manufacturer’s record includes ambitious appearance and biological claims. We have not established a controlled trial of this exact currently supplied formula demonstrating superiority to the other products in our files. Nor does a manufacturer description authorize applying a retail serum to a wound or using it during a procedure.

FDA distinguishes cosmetics and drugs partly through intended use and claims. That general distinction helps evaluate the type of statement being made; it is not a product-specific legal ruling from this publication. The microneedling fieldnote addresses why an ordinary topical product and a procedure combination require separate evidence.

A discussion of ingredient mechanisms may explain research interest, but it does not establish the size of a visible change for an individual. We have not assigned a firmness score, a wrinkle-reduction percentage, or an expected deadline for results.

Treat the displayed offer as a record, not a checkout quote

The official indexed page displayed €44.95 for 30 mL. Because direct retrieval did not provide a complete current product page, we do not present that amount as a verified live price or convert it into a US shopping recommendation. Shipping eligibility, taxes, availability, and the final currency need confirmation at the destination-specific checkout.

An introductory discount would also require its own eligibility check. A newsletter offer shown on a page is not a universal reduction for every reader. We did not create an account, submit contact details, or place an order to test the offer.

The comparison view retains this uncertainty rather than ranking the product by an attractive but incomplete number. Price and stock are different facts, and neither establishes whether the product fits an existing care plan.

What makes the review useful despite the gaps

The record supplies a concrete set of questions: which ingredient list matches current stock, what the percentage measures, which directions apply, and what the complete destination-specific purchase costs. Those questions are more useful than repeating the brand’s strongest promotional sentence as a finding.

For a differently described copper formulation, read the Skin Biology Super CP file. For our sponsored provider-guided option, the CoreAge file identifies its own missing formulation details. Each review should make the limits of the available information easier to see before a purchase.

SOURCE NOTES

What this record draws on

  1. Niche Beauty Lab — Theramid Copper Peptide ↗

    Indexed official record inspected: 30 mL, 3% copper-peptide claim, €44.95 display and ingredient/warning text. Direct and TinyFish retrieval returned a generic store shell; regional indexed ingredient records differed. Current shipment formula, stock, US total and live offer remain unverified. Accessed 2026-09-26.

  2. FDA — Cosmetics Labeling Guide ↗

    General ingredient-order rules, including the 1% or less exception and separate color-additive provisions. Not a determination about any particular product. Accessed 2026-09-26.

  3. AAD — Testing skincare products at home ↗

    General cosmetic home-testing and reaction guidance; medical patch testing is distinct. Page states last updated August 10, 2021; access date is not a new publication date. Accessed 2026-09-26.

  4. FDA — Cosmetic, drug, or both? ↗

    Explains intended use, product claims and the distinction between cosmetics and drugs. No separate legal category for cosmeceuticals. Accessed 2026-09-25.

Individual source access dates are recorded above. Prices, stock, labels, and directions can change. How we review.